(Q36776998)

English

Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications

scientific article published on 30 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

A R Kuykendal

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

L H Hendrix

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

R G Salloum

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

P A Godley

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

R C Chen

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

30 December 2012

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Annals of Oncology

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

24

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1338-1343

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Assessing the impact of a cooperative group trial on breast cancer care in the medicare population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Active surveillance for prostate cancer: progress and promise

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Impact of comorbidity on survival among men with localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Physician visits prior to treatment for clinically localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Outcomes of localized prostate cancer following conservative management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Survival following primary androgen deprivation therapy among men with localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

29 September 2017

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

27 June 2018

Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

27 June 2018

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Reimbursement policy and androgen-deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Changes in body composition during androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629897

5 September 2018

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS618

21 January 2018

4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variations in morbidity after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoporosis during continuous androgen deprivation: influence of the modality and length of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of neoadjuvant testicular androgen ablation therapy before radical prostatectomy in men with clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 2010 NCCN clinical practice guidelines in oncology on prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23277483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/ANNONC/MDS618

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36776998&oldid=1656023007"